ASH 2019 | Are Masp-2 levels after allo-HSCT associated with TMA development?

Name: Are Masp-2 levels after allo-HSCT associated with TMA development?
Uploaded: 2019-12-07T00:00:00.000Z
Duration: 4 min 22 s

Jeffrey Laurence • 7 Dec 2019

ASH 2019

General

A dangerous potential complication of allo-HSCT is thrombotic microangiopathy (TMA). Jeffrey Laurence, MD, Weill Cornell Medical College, Greenwich, CT, discusses a study (NCT02604420) investigating the level of Masp-2, a key part of lectin-dependent complement activation, following allo-HSCT in adults and its correlation with the development of TMA, which may have implications for anti-complement therapy. This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.